News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Cancer
Low CD4 cell count increases the risk of several cancers after starting HIV therapy

A large US study has provided important new insights into the incidence and timing of cancers among people taking antiretroviral therapy. Published in the online edition of

Published
12 June 2013
By
Michael Carter
Outcomes and prognosis
People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers

HIV-positive people taking antiretroviral therapy who have an undetectable viral load and a CD4 cell count above 500 cells/mm3 have a mortality risk comparable to that seen

Published
05 June 2013
By
Michael Carter
Starting treatment
AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa

AZT-based antiretroviral therapy is associated with lower increases in CD4 cell counts than other HIV treatment regimens, according to a study published in the online edition of

Published
22 May 2013
By
Michael Carter
Treatment guidelines
AIDS Healthcare Foundation Applauds WHO Decision to Initiate HIV Treatment Earlier

World Health Organization (WHO) announced this week at Treatment as Prevention conference in Vancouver, Canada, that it will raise treatment initiation guidelines for HIV-positive individuals from a CD4 count of less than 350 to a count of less than 500.

Published
25 April 2013
From
Wall Street Journal
UK health services
London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

Controversial changes to the range of anti-HIV drugs which are most commonly prescribed in London have resulted in a £7.2 million saving over two years, with no

Published
22 April 2013
By
Roger Pebody
Prevention of mother-to-child transmission
Study: In Malawi lifelong antiretroviral treatment for expectant moms “translates into saving more than 250,000 maternal life years”

A cost-effectiveness analysis of Option B+ in Malawi.

Published
27 March 2013
From
Science Speaks
Retention and linkage to care
Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi

Offering people the opportunity to self-test at home and then start antiretroviral therapy after counselling at home, together with home delivery of antiretroviral drugs, increased the number

Published
21 March 2013
By
Keith Alcorn
Outcomes and prognosis
In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Rates of AIDS-defining illnesses in the first year of antiretroviral therapy are significantly higher among migrant than non-migrant populations in resource-rich countries, investigators report in the online edition

Published
01 March 2013
By
Michael Carter
Starting treatment
Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

Antiretroviral combinations based on an integrase inhibitor are superior to other first-line HIV treatment regimens, according to the results of a meta-analysis published in the open access journal

Published
26 February 2013
By
Michael Carter
Starting treatment
When to Start ART in Africa — An Urgent Research Priority

We believe that a randomized, controlled trial should be undertaken immediately to determine when to initiate ART in Africa for maximal individual health benefit. It is feasible to conduct a large, simple trial to assess the risks and benefits of immediate ART versus deferral until a CD4+ count of 350 cells per cubic millimeter is reached.

Published
23 February 2013
From
New England Journal of Medicine
← First12345...56Next →

Filter by country